People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PERFUSIX USA, Inc. | — | Biotechnology | Pre-Seed | $800K | $44.2M | 2013 |
| TheraTec, Inc. | — | Other Health Care | Pre-Seed | $575K | $2.5M | 2023 |
Tom Waddell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tom Waddell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Jaynes | 1 | 3 |
| Tom Brust | 1 | 2 |
| James Edgemond | 1 | 1 |
| Tim Klug | 1 | 1 |
| Shaf Keshavjee | 1 | 1 |
| Tony Hyk | 1 | 1 |
| Juli Denny | 1 | 1 |
| Adam Rondeau | 1 | 1 |
| Kurt Goos | 1 | 1 |
| RT Donahue | 1 | 1 |
| Julie Denny | 1 | 1 |
| Marcelo Cypel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.